Long-Term Follow-up of Phase II Study of Chemotherapy Plus Dasatinib for the Initial Treatment of Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

BACKGROUND: The long-term efficacy of combination of chemotherapy with dasatinib in patients with Philadelphia-chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) is not well-established. METHODS: Patients received dasatinib with 8 cycles of alternating hyperCVAD and high dose cytarabine an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Ravandi, Farhad, O'Brien, Susan, Cortes, Jorge, Thomas, Deborah, Garris, Rebecca, Faderl, Stefan, Burger, Jan, Rytting, Michael, Ferrajoli, Alessandra, Wierda, William, Verstovsek, Srdan, Champlin, Richard, Kebriaei, Partow, McCue, Deborah, Huang, Xuelin, Jabbour, Elias, Garcia-Manero, Guillermo, Estrov, Zeev, Kantarjian, Hagop
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666803/
https://ncbi.nlm.nih.gov/pubmed/26308885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29646
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares